Literature DB >> 29926186

Reply to the letter "How to standardize the evaluation of tumor regression grading of gastrointestinal cancers after neoadjuvant therapy?" by Dr. Nasierowska-Guttmejer and Dr. Szawlowski, VIAR-D-18-00181.

Rupert Langer1, Karen Becker2,3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29926186     DOI： 10.1007/s00428-018-2392-3

Source DB:  PubMed          Journal:  Virchows Arch        ISSN： 0945-6317            Impact factor:   4.064


× No keyword cloud information.
  6 in total

1.  Just how useful an endpoint is complete pathological response after neoadjuvant chemoradiation in rectal cancer?

Authors:  Rob Glynne-Jones; Nicola Anyamene
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-10-01       Impact factor: 7.038

2.  Tumour regression grading in patients with residual rectal cancer after preoperative chemoradiation.

Authors:  Krzysztof Bujko; Milena Kolodziejczyk; Anna Nasierowska-Guttmejer; Wojciech Michalski; Lucyna Kepka; Ewa Chmielik; Andrzej Wojnar; Maciej Chwalinski
Journal:  Radiother Oncol       Date:  2010-04-27       Impact factor: 6.280

Review 3.  Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is now.

Authors:  Tom P MacGregor; Tim S Maughan; Ricky A Sharma
Journal:  J Clin Pathol       Date:  2012-06-25       Impact factor: 3.411

Review 4.  Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy.

Authors:  Rupert Langer; Karen Becker
Journal:  Virchows Arch       Date:  2017-09-16       Impact factor: 4.064

5.  Distal intramural spread of rectal cancer after preoperative radiotherapy: the results of a multicenter randomized clinical study.

Authors:  Ewa Chmielik; Krzysztof Bujko; Anna Nasierowska-Guttmejer; Marek P Nowacki; Lucyna Kepka; Rafal Sopylo; Andrzej Wojnar; Przemyslaw Majewski; Jacek Sygut; Andrzej Karmolinski; Tomasz Huzarski; Piotr Wandzel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-03-10       Impact factor: 7.038

6.  Neoadjuvant treatment for unresectable rectal cancer: an interim analysis of a multicentre randomized study.

Authors:  Krzysztof Bujko; Anna Nasierowska-Guttmejer; Lucjan Wyrwicz; Małgorzata Malinowska; Jacek Krynski; Ewa Kosakowska; Andrzej Rutkowski; Lucyna Pietrzak; Lucyna Kepka; Jakub Radziszewski; Marta Olszyna-Serementa; Magdalena Bujko; Anna Danek; Mariusz Kryj; Jerzy Wydmanski; Wojciech Zegarski; Wlodzimierz Markiewicz; Tadeusz Lesniak; Ireneusz Zygulski; Dorota Porzuczek-Zuziak; Marek Bebenek; Adam Maciejczyk; Wojciech Polkowski; Beata Czeremszynska; Ewa Cieslak-Zeranska; Zygmunt Toczko; Andrzej Radkowski; Leszek Kolodziejski; Marek Szczepkowski; Adam Majewski; Michal Jankowski
Journal:  Radiother Oncol       Date:  2013-04-13       Impact factor: 6.280
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.